SBS Share Price Performance
€0
-26.90 (-100.00%)
Price €0
Fair Value€25.40
Share Pricen/a
Narrative Update • Jun 17
Stratec SE Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 7 Fair Values set on narratives written by author
SBS Community Narratives
AN
Fair Value
·Fair Value €25.4 2.6% undervalued intrinsic discount
SBS: Future Leadership Will Drive Healthcare Diagnostics Forward Amidst Margin Pressures
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
Fair Value
·Fair Value €20 23.8% overvalued intrinsic discount
Weak Product Launches Will Drag Performance Despite Emerging Opportunity
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value
·Fair Value €34 27.2% undervalued intrinsic discount
Aging Populations And Automation Will Spur Diagnostic Demand
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Stratec
2.6% undervalued intrinsic discount
SBS: Future Leadership Will Drive Healthcare Diagnostics Forward Amidst Margin Pressures
View narrativeAN
Updated 17 Jun
Stratec
23.8% overvalued intrinsic discount
Weak Product Launches Will Drag Performance Despite Emerging Opportunity
View narrativeAN
Updated 2 Jun
Stratec
27.2% undervalued intrinsic discount
Aging Populations And Automation Will Spur Diagnostic Demand
View narrativeAN
Updated 21 Apr
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
SBS: Future Upside Will Rely On Reset Margins And Lower P/E
Fair Value: €25.4 2.6% undervalued intrinsic discount
3 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
SBS: Lowered Multiples And Stable Margins Will Support Future Upside Potential
Fair Value: €20 23.8% overvalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
SBS: Rebased Fair Value And 2025 Margin Guidance Will Define Upside Potential
Fair Value: €34 27.2% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Stratec SE Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Nov 12, 2026
- -0.032
- 23.57%
- -0.16%
- 44.0%
About SBS
- Founded
- 1979
- Employees
- 1383
- CEO
- WebsiteView website
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.
